Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia
- Resource Type
- Article
- Source
- In
Neoplasia January 2018 20(1):1-11 - Subject
- Language
- ISSN
- 1476-5586